Source: iQoncept / Shutterstock
Soleno Therapeutics (NASDAQ:SLNO) just reported results for the first quarter of 2024.
- Soleno Therapeutics reported earnings per share of -59 cents. This was below the analyst estimate for EPS of -37 cents.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/slno-stock-earnings-soleno-therapeutics-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC